{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T02:11:30Z","timestamp":1787451090578,"version":"build-2736575974"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,16]],"date-time":"2021-02-16T00:00:00Z","timestamp":1613433600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,2,16]],"date-time":"2021-02-16T00:00:00Z","timestamp":1613433600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EJNMMI radiopharm. chem."],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Increased vascular permeability is an early sign of vascular damage and can be measured with the transcapillary escape rate of albumin (TER\n                      <jats:sub>alb<\/jats:sub>\n                      ). Although TER\n                      <jats:sub>alb<\/jats:sub>\n                      has a multi-exponential kinetic model, most published TER\n                      <jats:sub>alb<\/jats:sub>\n                      data are based on mono-exponential kinetic models with variation in blood sampling schemes. Aim of this posthoc study was to evaluate the influence of variation in blood sampling schemes and the impact of mono- or bi-exponential analyses on the calculation of TER\n                      <jats:sub>alb<\/jats:sub>\n                      . Study participants were part of a cross-over intervention study protocol, investigating effects of sodium loading on blood pressure, endothelial surface layer and microcirculation. Multiple blood samples were drawn between 3 and 60\u2009min after injection of radioactive iodide labeled human serum albumin (rHSA).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In total 27 male participants with 54 measurements were included. For all participants the maximum serum radioactivity was reached within 20\u2009min, while 85% of the participants had their maximum serum activity within 10\u2009min. The TER\n                      <jats:sub>alb<\/jats:sub>\n                      calculated with the subsequently chosen T\n                      <jats:sub>20\u201360 min<\/jats:sub>\n                      reference scheme (6.19\u2009\u00b1\u20090.49%\/h) was significantly lower compared to the TER\n                      <jats:sub>alb<\/jats:sub>\n                      of the T\n                      <jats:sub>3\u201360 min<\/jats:sub>\n                      , T\n                      <jats:sub>5\u201360 min<\/jats:sub>\n                      , and T\n                      <jats:sub>max \u2013 60 min<\/jats:sub>\n                      schemes. There was no significant difference between the T\n                      <jats:sub>20\u201360 min<\/jats:sub>\n                      reference scheme and the T\n                      <jats:sub>10\u201360 min<\/jats:sub>\n                      and T\n                      <jats:sub>15\u201360 min<\/jats:sub>\n                      schemes. Bi-exponential kinetic modeling did not result in significant different observations compared to the mono-exponential kinetic analysis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      As there is variation in the timing of the maximum serum radioactivity of rHSA, blood sampling schemes starting before 10\u2009min after administration of rHSA will result in a significant overestimation of TER\n                      <jats:sub>alb<\/jats:sub>\n                      . In addition, variation in kinetic modeling did not result in significant changes in TER\n                      <jats:sub>alb<\/jats:sub>\n                      . Therefore, we emphasize the need to standardize TER\n                      <jats:sub>alb<\/jats:sub>\n                      and for practical and logistical reasons advocate the use of a mono-exponential model with blood sampling starting 20\u2009min after rHSA administration.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s41181-021-00125-0","type":"journal-article","created":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T12:11:43Z","timestamp":1613563903000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Transcapillary escape rate of 125I-albumin in relation to timing of blood sampling: the need for standardization"],"prefix":"10.1186","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6223-3454","authenticated-orcid":false,"given":"Youssef","family":"Chahid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nienke M. G.","family":"Rorije","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soufian","family":"el Boujoufi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron A. A.","family":"Math\u00f4t","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liffert","family":"Vogt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hein J.","family":"Verberne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,16]]},"reference":[{"key":"125_CR1","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.colsurfb.2013.08.025","volume":"112","author":"K Balakumar","year":"2013","unstructured":"Balakumar K, Raghavan CV, Selvan NT, Prasad RH, Abdu S. Self nanoemulsifying drug delivery system (SNEDDS) of rosuvastatin calcium: design, formulation, bioavailability and pharmacokinetic evaluation. Colloids Surf B Biointerfaces. 2013;112:337\u201343.","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"9","key":"125_CR2","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1172\/JCI103184","volume":"34","author":"A Bauman","year":"1955","unstructured":"Bauman A, Rothschild MA, Yalow RS, Berson SA. Distribution and metabolism of I131 labeled human serum albumin in congestive heart failure with and without proteinuria. J Clin Invest. 1955;34(9):1359\u201368.","journal-title":"J Clin Invest"},{"issue":"8","key":"125_CR3","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1172\/JCI102789","volume":"32","author":"SA Berson","year":"1953","unstructured":"Berson SA, Yalow RS, Schreiber SS, Post J. Tracer experiments with I131 labeled human serum albumin: distribution and degradation studies. J Clin Invest. 1953;32(8):746\u201368.","journal-title":"J Clin Invest"},{"issue":"12","key":"125_CR4","doi-asserted-by":"publisher","first-page":"2646","DOI":"10.1007\/s00125-010-1910-x","volume":"53","author":"LN Broekhuizen","year":"2010","unstructured":"Broekhuizen LN, Lemkes BA, Mooij HL, Meuwese MC, Verberne H, Holleman F, et al. Effect of sulodexide on endothelial glycocalyx and vascular permeability in patients with type 2 diabetes mellitus. Diabetologia. 2010;53(12):2646\u201355.","journal-title":"Diabetologia"},{"key":"125_CR5","unstructured":"CIS bio international. Summary of product characteristics of SERALB-125. France: CIS bio international; 2010."},{"issue":"10","key":"125_CR6","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.1093\/jac\/dkw226","volume":"71","author":"F de Velde","year":"2016","unstructured":"de Velde F, de Winter BC, Koch BC, van Gelder T, Mouton JW. Consortium C-N. non-linear absorption pharmacokinetics of amoxicillin: consequences for dosing regimens and clinical breakpoints. J Antimicrob Chemother. 2016;71(10):2909\u201317.","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"125_CR7","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1067\/mcp.2000.109787","volume":"68","author":"G Dell\u2019Omo","year":"2000","unstructured":"Dell\u2019Omo G, Bandinelli S, Penno G, Pedrinelli R, Mariani M. Simvastatin, capillary permeability, and acetylcholine-mediated vasomotion in atherosclerotic, hypercholesterolemic men. Clin Pharmacol Ther. 2000;68(4):427\u201334.","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"125_CR8","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1042\/CS20060165","volume":"111","author":"G Dell'omo","year":"2006","unstructured":"Dell'omo G, Penno G, Pucci L, Lucchesi D, Fotino C, Del Prato S, et al. ACE gene insertion\/deletion polymorphism modulates capillary permeability in hypertension. Clin Sci. 2006;111(6):357\u201364.","journal-title":"Clin Sci"},{"key":"125_CR9","doi-asserted-by":"publisher","first-page":"e4794","DOI":"10.7717\/peerj.4794","volume":"6","author":"XA Harrison","year":"2018","unstructured":"Harrison XA, Donaldson L, Correa-Cano ME, Evans J, Fisher DN, Goodwin CED, et al. A brief introduction to mixed effects modelling and multi-model inference in ecology. Peer J. 2018;6:e4794.","journal-title":"Peer J"},{"issue":"2","key":"125_CR10","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1152\/jappl.1997.83.2.407","volume":"83","author":"A Haskell","year":"1997","unstructured":"Haskell A, Nadel ER, Stachenfeld NS, Nagashima K, Mack GW. Transcapillary escape rate of albumin in humans during exercise-induced hypervolemia. J Appl Physiol. 1997;83(2):407\u201313.","journal-title":"J Appl Physiol"},{"issue":"6","key":"125_CR11","doi-asserted-by":"publisher","first-page":"589","DOI":"10.3109\/00365518109090503","volume":"41","author":"JH Henriksen","year":"1981","unstructured":"Henriksen JH, Schlichting P. Increased extravasation and lymphatic return rate of albumin during diuretic treatment of ascites in patients with liver cirrhosis. Scand J Clin Lab Invest. 1981;41(6):589\u201399.","journal-title":"Scand J Clin Lab Invest"},{"issue":"7","key":"125_CR12","doi-asserted-by":"publisher","first-page":"653","DOI":"10.3109\/00365519209115509","volume":"52","author":"EW Jensen","year":"1992","unstructured":"Jensen EW, Bryde Andersen H, Nielsen SL, Christensen NJ. Long-term smoking increases transcapillary escape rate of albumin. Scand J Clin Lab Invest. 1992;52(7):653\u20136.","journal-title":"Scand J Clin Lab Invest"},{"issue":"9","key":"125_CR13","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1161\/01.ATV.15.9.1324","volume":"15","author":"JS Jensen","year":"1995","unstructured":"Jensen JS. Renal and systemic transvascular albumin leakage in severe atherosclerosis. Arterioscler Thromb Vasc Biol. 1995;15(9):1324\u20139.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"125_CR14","doi-asserted-by":"crossref","first-page":"54","DOI":"10.17305\/bjbms.2016.1515","volume":"17","author":"A Kulo","year":"2017","unstructured":"Kulo A, Smits A, Maleskic S, Van de Velde M, Van Calsteren K, De Hoon J, et al. Enantiomer-specific ketorolac pharmacokinetics in young women, including pregnancy and postpartum period. Bosn J Basic Med Sci. 2017;17(1):54\u201360.","journal-title":"Bosn J Basic Med Sci"},{"issue":"5","key":"125_CR15","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1152\/japplphysiol.00201.2001","volume":"92","author":"MP Margarson","year":"2002","unstructured":"Margarson MP, Soni NC. Effects of albumin supplementation on microvascular permeability in septic patients. J Appl Physiol. 2002;92(5):2139\u201345.","journal-title":"J Appl Physiol"},{"issue":"6","key":"125_CR16","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.114.001274","volume":"3","author":"HL Mooij","year":"2014","unstructured":"Mooij HL, Cabrales P, Bernelot Moens SJ, Xu D, Udayappan SD, Tsai AG, et al. Loss of function in heparan sulfate elongation genes EXT1 and EXT 2 results in improved nitric oxide bioavailability and endothelial function. J Am Heart Assoc. 2014;3(6):e001274.","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"125_CR17","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.2337\/diacare.20.6.1019","volume":"20","author":"M Nannipieri","year":"1997","unstructured":"Nannipieri M, Penno G, Rizzo L, Pucci L, Bandinelli S, Mattei P, et al. Transcapillary escape rate of albumin in type II diabetic patients. The relationship with microalbuminuria and hypertension. Diabetes Care. 1997;20(6):1019\u201326.","journal-title":"Diabetes Care"},{"issue":"1","key":"125_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2337\/diacare.18.1.1","volume":"18","author":"M Nannipieri","year":"1995","unstructured":"Nannipieri M, Rizzo L, Rapuano A, Pilo A, Penno G, Navalesi R. Increased transcapillary escape rate of albumin in microalbuminuric type II diabetic patients. Diabetes Care. 1995;18(1):1\u20139.","journal-title":"Diabetes Care"},{"issue":"7","key":"125_CR20","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s00228-014-1680-3","volume":"70","author":"L Nezic","year":"2014","unstructured":"Nezic L, Derungs A, Bruggisser M, Tschudin-Sutter S, Krahenbuhl S, Haschke M. Therapeutic drug monitoring of once daily aminoglycoside dosing: comparison of two methods and investigation of the optimal blood sampling strategy. Eur J Clin Pharmacol. 2014;70(7):829\u201337.","journal-title":"Eur J Clin Pharmacol"},{"issue":"8","key":"125_CR21","doi-asserted-by":"publisher","first-page":"e0136371","DOI":"10.1371\/journal.pone.0136371","volume":"10","author":"A Norberg","year":"2015","unstructured":"Norberg A, Rooyackers O, Segersvard R, Wernerman J. Albumin kinetics in patients undergoing major abdominal surgery. PLoS One. 2015;10(8):e0136371.","journal-title":"PLoS One"},{"issue":"6","key":"125_CR22","first-page":"217","volume":"22","author":"HH Parving","year":"1975","unstructured":"Parving HH. Microvascular permeability to plasma proteins in hypertension and diabetes mellitus in man--on the pathogenesis of hypertensive and diabetic microangiopathy. Dan Med Bull. 1975;22(6):217\u201333.","journal-title":"Dan Med Bull"},{"issue":"5","key":"125_CR23","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1161\/01.RES.32.5.643","volume":"32","author":"HP Parving","year":"1973","unstructured":"Parving HP, Gyntelberg F. Transcapillary escape rate of albumin and plasma volume in essential hypertension. Circ Res. 1973;32(5):643\u201351.","journal-title":"Circ Res"},{"issue":"3","key":"125_CR24","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S0895-7061(00)00250-8","volume":"13","author":"R Pedrinelli","year":"2000","unstructured":"Pedrinelli R, Dell'Omo G, Bandinelli S, Penno G, Mariani M. Transvascular albumin leakage and forearm vasodilatation to acetylcholine in essential hypertension. Am J Hypertens. 2000;13(3):256\u201361.","journal-title":"Am J Hypertens"},{"issue":"3","key":"125_CR25","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1161\/01.HYP.34.3.491","volume":"34","author":"R Pedrinelli","year":"1999","unstructured":"Pedrinelli R, Penno G, Dell\u2019Omo G, Bandinelli S, Giorgi D, Di Bello V, et al. Microalbuminuria and transcapillary albumin leakage in essential hypertension. Hypertension. 1999;34(3):491\u20135.","journal-title":"Hypertension"},{"issue":"2","key":"125_CR27","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1097\/ALN.0000000000001989","volume":"128","author":"NMG Rorije","year":"2018","unstructured":"Rorije NMG, Olde Engberink RHG, Chahid Y, van Vlies N, van Straalen JP, van den Born BH, et al. Microvascular permeability after an acute and chronic salt load in healthy subjects: a randomized open-label crossover intervention study. Anesthesiology. 2018;128(2):352\u201360.","journal-title":"Anesthesiology"},{"issue":"4","key":"125_CR28","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/1523-1747.ep12506718","volume":"78","author":"B Staberg","year":"1982","unstructured":"Staberg B, Worm AM, Rossing N, Brodthagen H. Microvascular leakage of plasma proteins after PUVA and UVA. J Invest Dermatol. 1982;78(4):261\u20133.","journal-title":"J Invest Dermatol"},{"issue":"2","key":"125_CR29","doi-asserted-by":"publisher","first-page":"R157","DOI":"10.1186\/cc3050","volume":"9","author":"LT van Eijk","year":"2005","unstructured":"van Eijk LT, Pickkers P, Smits P, van den Broek W, Bouw MP, van der Hoeven JG. Microvascular permeability during experimental human endotoxemia: an open intervention study. Crit Care. 2005;9(2):R157\u201364.","journal-title":"Crit Care"},{"issue":"1","key":"125_CR30","doi-asserted-by":"publisher","first-page":"e001039","DOI":"10.1136\/bmjdrc-2019-001039","volume":"8","author":"EFE Wenstedt","year":"2020","unstructured":"Wenstedt EFE, Rorije NMG, Olde Engberink RHG, van der Molen KM, Chahid Y, Danser AHJ, et al. Effect of high-salt diet on blood pressure and body fluid composition in patients with type 1 diabetes: randomized controlled intervention trial. BMJ Open Diabet Res Care. 2020;8(1):e001039.","journal-title":"BMJ Open Diabet Res Care"},{"issue":"3","key":"125_CR31","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.cmpb.2010.01.007","volume":"99","author":"Y Zhang","year":"2010","unstructured":"Zhang Y, Huo M, Zhou J, Xie S. PKSolver: an add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft excel. Comput Methods Prog Biomed. 2010;99(3):306\u201314.","journal-title":"Comput Methods Prog Biomed"},{"issue":"12","key":"125_CR32","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1681\/ASN.V5122057","volume":"5","author":"R Zietse","year":"1995","unstructured":"Zietse R, Derkx FH, Weimar W, Schalekamp MA. Effect of atrial natriuretic peptide on renal and vascular permeability in diabetes mellitus. J Am Soc Nephrol. 1995;5(12):2057\u201366.","journal-title":"J Am Soc Nephrol"}],"container-title":["EJNMMI Radiopharmacy and Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s41181-021-00125-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s41181-021-00125-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s41181-021-00125-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T16:22:14Z","timestamp":1671294134000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejnmmipharmchem.springeropen.com\/articles\/10.1186\/s41181-021-00125-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,16]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["125"],"URL":"https:\/\/doi.org\/10.1186\/s41181-021-00125-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-99396\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-99396\/v1","asserted-by":"object"}]},"ISSN":["2365-421X"],"issn-type":[{"value":"2365-421X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,16]]},"assertion":[{"value":"29 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All participants provided written informed consent and approval was obtained from the local ethics committee. The trial is registered in the Netherlands Trial Register (NTR4095 and NTR4788).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9"}}